跳至主要内容
临床试验/NCT06295640
NCT06295640进行中(未招募)不适用

Relative Contribution of Brain Insulin Action for Postprandial Metabolism

University of Ulm1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2024年3月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
31
试验地点
1
主要终点
Endogenous glucose production

研究概览

简要总结

The goal of this clinical trial is to clarify (i) the contribution of brain insulin action on regulation of systemic metabolism, (ii) sex-specific differences in the central regulation and (iii) the influence of the menstrual cycle in women.

Therefore, participants will undergo oral glucose tolerance tests combined with a double tracer dilution technique. This approach will be compared between days with insulin delivery to the brain as nasal spray and days with placebo spray.

详细描述

This research project aims to investigate to what extent brain insulin action is responsible for the control of postprandial metabolism compared to direct effects of insulin in peripheral target tissues. Furthermore, the study will investigate sex differences and the influence of the menstrual cycle on brain-derived coordination of postprandial signaling for metabolic control.

Therefore, insulin action in the brain will be introduced by application of insulin as nasal spray (on one day) versus carrier solution as placebo nasal spray (on another day) in a randomized, blinded fashion. Spray administration will be performed 15 minutes before a 75 gram oral glucose tolerance test that will introduce a postprandial state. On placebo day, the known spillover of tiny amounts of nasal insulin into the systemic circulation will be mimicked by an appropriate i.v. insulin bolus. This approach will be combined with a double-tracer dilution technique. Labeled glucose ([6,6-2H]glucose) will be infused 120 minutes before and during the OGTT (180 min) and will be used to address endogenous glucose production. The glucose drink from the OGTT will be enriched with [U-13C6]glucose to compute the glucose appearance rate (Ra). Basal endogenous glucose production will be calculated as well as post-load endogenous glucose production and rates of glucose disappearances (Rd). Using this approach, brain-derived regulation of postprandial metabolism including endogenous glucose production, glucose disappearance, insulin secretion, and secretion of proglucagon-cleavage products (incretins) will be examined.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI < 24 kg/m2
  • no known primary diseases
  • no hormonal contraception

排除标准

  • Alcohol or drug abuse
  • At screening: Hb < 12 g/dl for women and Hb < 14 g/dl for men
  • Any (clinical) condition that would endanger participant's safety or question scientific success according to a physician's opinion.

研究组 & 干预措施

Intranasal insulin spray

Experimental

160 Units of human insulin as nasal spray

干预措施: Oral glucose tolerance test with double-tracer dilution and intranasal insulin spray (Other)

Placebo spray

Placebo Comparator

Nasal spray containing placebo solution

干预措施: Oral glucose tolerance test with double-tracer dilution and intranasal placebo spray (Other)

结局指标

主要结局

Endogenous glucose production

时间窗: -120 minutes - 180 minutes during oral glucose tolerance test

Effect of intranasal insulin versus placebo on endogenous glucose production assessed with Steele's non-steady state model during an oral glucose tolerance test combined with double-tracer dilution technique.

Rate of glucose disappearance

时间窗: -120 minutes - 180 minutes during oral glucose tolerance test

Effect of intranasal insulin versus placebo on rate of glucose disappearance (Rd) assessed with Steele's non-steady state model during an oral glucose tolerance test combined with double-tracer dilution technique.

次要结局

  • Post-absorptive energy expenditure(30 minutes and 180 minutes during oral glucose tolerance test)
  • Sex differences(-120 minutes - 180 minutes during oral glucose tolerance test)
  • Autonomic nervous system activity(-15 minutes - 180 minutes during oral glucose tolerance test)
  • Glucose tolerance(0-120 minutes during oral glucose tolerance test)
  • Whole-body insulin sensitivity(0-120 minutes during oral glucose tolerance test)
  • Proglucagon cleavage products(0-120 minutes during oral glucose tolerance test)
  • Insulin secretion(0-180 minutes during oral glucose tolerance test)
  • Menstrual cycle effects(-120 minutes - 180 minutes during oral glucose tolerance test)

研究者

发起方
University of Ulm
申办方类型
Other
责任方
Principal Investigator
主要研究者

Martin Heni

Prof. Dr. med. Martin Heni

University of Ulm

研究点 (1)

Loading locations...

相似试验